Real Estate
Parkway Life Real Estate Investment Trust(PRKWF)
Live Price
Offline$3.20
+0.00% today
Window Change
+0.00%
Window
May 29, 2026 โ Jun 12, 2026
- Market Cap
- $2.62B
- Revenue Growth
- +13.5%
- EPS Growth
- +43.8%
- Dividend Yield
- 3.8%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 11 bars ยท May 29, 2026 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Parkway Life Real Estate Investment Trust (PRKWF) is a Real Estate stock with a market cap of $2.62B and listed on OTC. The stock last traded around $3.20 and up 0.0% across the available one-year price window (May 29, 2026 โ Jun 12, 2026). Baseline metrics include revenue growth of +13.5%, EPS growth of +43.8%, a dividend yield of 3.8%. What stands out right now is revenue +13.5%, EPS +43.8%, free cash flow -100.0% with operating margin 76.5% and ROIC 3.1%. The dividend matters to the case here, with a current yield around 3.8%. Valuation already assumes a fairly strong business story at P/E 38.7 and price/sales 22.8. Stock Foundry combines PRKWF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Real Estate peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+13.5% vs +11.4% peer median
Operating Margin
Above sector median
+76.5% vs +59.6% peer median
P/E
Above sector median
38.7 vs 19.5 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Feb 1, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +13.5% and EPS at +43.8%, with operating margin around 76.5%.
The next real check-in already has a date
The next earnings event is scheduled for Jul 28, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PRKWF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PRKWF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PRKWF and SPY.
Company Overview
Parkway Life Real Estate Investment Trust
Other OTC
Parkway Life Real Estate Investment Trust ("PLife REIT") is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 54 properties located in the Asia Pacific region, with a total portfolio size of approximately S$2.02 billion3 as at 31 December 2020. It owns the largest portfolio of strategically-located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 50 assets of high quality nursing home and care facility properties in various prefectures of Japan. It also owns strata-titled units/lots in MOB Specialist Clinics Kuala Lumpur in Malaysia.
- Leadership
- Yean Chau Yong
- IPO Date
- Apr 21, 2011
- Employees
- 23
- Street Address
- 80 Robinson Road, No. 02-00
- Mailing
- Singapore, 068898
- Region
- Singapore, SG
- Reporting Currency
- USD
- Investor Line
- 65 6236 4333
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 38.7
- EV/EBITDA
- โ
- Price/Sales
- 22.8
- Price/Book
- 1.6
Growth
- Revenue
- +13.5%
- EPS
- +43.8%
- Free Cash Flow
- -100.0%
Profitability
- Gross Margin
- 87.1%
- Operating Margin
- 76.5%
- Net Margin
- 58.8%
- ROE
- 4.2%
- ROIC
- 3.1%
Balance Sheet
- Debt/Equity
- 0.53
- Current Ratio
- 0.27
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.